Chronic Apocynin Treatment Attenuates Beta Amyloid Plaque Size and Microglial Number in hAPP751SL MiceReportar como inadecuado




Chronic Apocynin Treatment Attenuates Beta Amyloid Plaque Size and Microglial Number in hAPP751SL Mice - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Background

NADPH oxidase is implicated in neurotoxic microglial activation and the progressive nature of Alzheimer-s Disease AD. Here, we test the ability of two NADPH oxidase inhibitors, apocynin and dextromethorphan DM, to reduce learning deficits and neuropathology in transgenic mice overexpressing human amyloid precursor protein with the Swedish and London mutations hAPP751SL.

Methods

Four month old hAPP751SL mice were treated daily with saline, 15 mg-kg DM, 7.5 mg-kg DM, or 10 mg-kg apocynin by gavage for four months.

Results

Only hAPP751SL mice treated with apocynin showed reduced plaque size and a reduction in the number of cortical microglia, when compared to the saline treated group. Analysis of whole brain homogenates from all treatments tested saline, DM, and apocynin demonstrated low levels of TNFα, protein nitration, lipid peroxidation, and NADPH oxidase activation, indicating a low level of neuroinflammation and oxidative stress in hAPP751SL mice at 8 months of age that was not significantly affected by any drug treatment. Despite in vitro analyses demonstrating that apocynin and DM ameliorate Aβ-induced extracellular superoxide production and neurotoxicity, both DM and apocynin failed to significantly affect learning and memory tasks or synaptic density in hAPP751SL mice. To discern how apocynin was affecting plaque levels plaque load and microglial number in vivo, in vitro analysis of microglia was performed, revealing no apocynin effects on beta-amyloid Aβ phagocytosis, microglial proliferation, or microglial survival.

Conclusions

Together, this study suggests that while hAPP751SL mice show increases in microglial number and plaque load, they fail to exhibit elevated markers of neuroinflammation consistent with AD at 8 months of age, which may be a limitation of this animal model. Despite absence of clear neuroinflammation, apocynin was still able to reduce both plaque size and microglial number, suggesting that apocynin may have additional therapeutic effects independent of anti-inflammatory characteristics.



Autor: Melinda E. Lull, Shannon Levesque, Michael J. Surace, Michelle L. Block

Fuente: http://plos.srce.hr/



DESCARGAR PDF




Documentos relacionados